Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Guidelines for the performance of CD4+ T-cell determinations in persons with human immunodeficiency virus infection
  • Published Date:
    May 8, 1992
  • Status:
    superseded
    | This document has been replaced by:
  • Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 1992; 41(RR-8):1-17.
  • Language:
    English
Filetype[HTML]
View this content


This is an HTML document so it cannot be previewed.
To open, click the "View" button.
Details:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Guidelines for performing single-platform absolute CD4+ T-cell determinations with CD45 gating for persons infected with human immunodeficiency virus
    Personal Author:
    Mazurek, Gerald H.; McDougal, J. Steven; Nicholson, Janet K. A., 1948-; Villarino, Margarita E.;
    Corporate Authors:
    National Center for HIV, STD, and TB Prevention (U.S.), Division of Tuberculosis Elimination.. Centers for Disease Control and Preventiom (U.S.). National Center for Infectious Diseases (U.S.). National Center for Infectious Diseases (U.S.), Division of AIDS, STD, and TB Laboratory Research..
    Published Date:
    January 31, 2003
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 52, no. RR-2
    Description:
    These guidelines were developed by CDC for laboratorians who perform immunophenotyping for detection and enumeration of CD4+ T-cells and other lymphocyte subsets in persons infected with human immunodeficiency virus (HIV). The guidelines describe sin...
    Status:
    current
    File Type:
    Filetype[PDF - 397.77 KB]
  2. 1997 revised guidelines for performing CD4+ T-cell determinations in persons infected with human immunodeficiency virus (HIV)
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    January 10, 1997
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 1997; 46(RR-2):1-29.
    Description:
    Human immunodeficiency virus counseling and testing services (HIV-CTS) have been recommended by CDC since 1985, when serologic tests became available to detect antibodies to HIV (1,2). In August 1987, CDC published the Public Health Service Guideline...
    File Type:
    Filetype[PDF - 311.48 KB]
  3. Guidelines for Using the QuantiFERON-TB Test for Diagnosing Latent Mycobacterium Tuberculosis Infection. Centers for Disease Control and Prevention
    Corporate Authors:
    National Center for HIV, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination.
    Published Date:
    January 31, 2003
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 2003; 52(RR-2):15-8.
    Description:
    This statement provides new recommendations for targeted tuberculin testing and treatment regimens for persons with latent tuberculosis infection (LTBI) and updates previously published guidelines (1,2). This statement is issued in recognition of the...
    File Type:
    Filetype[PDF - 397.77 KB]
  4. 1994 revised guidelines for the performance of CD4+ T-cell determinations in persons with human immunodeficiency virus (HIV) infections
    Personal Author:
    Nicholson, Janet K. A., 1948-; McDougal, J. Steven; Hearn, Thomas L.; Collins, Carlyn L.; Velleca, Wallis M.; Jones, Wanda K.; Gerber, A. Russell;
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). Public Health Practice Program Office.. National Center for Infectious Diseases (U.S.). National Center for Prevention Services (U.S.).
    Published Date:
    March 4, 1994
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 1994; 43(RR-3):1-21.
    Series:
    DHEW publication ; no. (NIOSH) 2004-124
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 43, no. RR-3
    Description:
    The Food and Drug Administration (FDA) has recommended that all donated blood be screened for antibodies to human immunodeficiency virus type 2 (HIV-2) beginning no later than June 1, 1992. This article provides CDC recommendations for the DIAGNOSIS ...
    File Type:
    Filetype[PDF - 317.63 KB]
  5. 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age [and] Official authorized addenda; human immunodeficiency virus infection codes and official guidelines for coding and reporting ICD-9-CM
    Personal Author:
    Caldwell, M. Blake; Lindegren, Mary Lou; Lurie, Perrianne; Oxtoby, Margaret; Rogers, Martha F.; Simonds, Robert J.;
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). National Center for Health Statistics (U.S.), Division of Health Care Statistics.. National Center for Infectious Diseases (U.S.), Division of HIV/AIDS.. World Health Organization.
    Published Date:
    September 30, 1994
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 43, no. RR-12
    Description:
    1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age: This revised classification system for human immunodeficiency virus (HIV) infection in children replaces the pediatric HIV classifica...
    File Type:
    Filetype[PDF - 310.03 KB]